# An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

> **NCT02573077** · — · COMPLETED · sponsor: **Otsuka Pharmaceutical Europe Ltd** · enrollment: 69 (actual)

## Conditions studied

- Hyponatremia
- Syndrome of Inappropriate ADH (SIADH) Secretion
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02573077
- **Lead sponsor:** Otsuka Pharmaceutical Europe Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-12-13
- **Final completion:** 2017-12-13
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02573077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02573077, "An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02573077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*